AQR group (VRXA) discloses 658,138-share Veraxa Biotech position under 5% threshold

Rhea-AI Filing Summary

AQR Capital Management, LLC, together with AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC, reports its beneficial ownership in Veraxa Biotech Holding AG Ordinary Shares on an amended basis. The group reports beneficial ownership of 658,138 Ordinary Shares, including warrants representing 658,138 Ordinary Shares, par value CHF 100/11,325 per share.

This position represents 0.46% of Veraxa’s outstanding Ordinary Shares. The AQR entities report no sole voting or dispositive power, and shared voting and shared dispositive power over all 658,138 shares. The filing confirms that the AQR group now holds 5% or less of this class of securities.

Key Figures

Beneficially owned shares: 658,138 Ordinary Shares Ownership percentage: 0.46% Shared voting power: 658,138 +2 more

5 metrics

Beneficially owned shares 658,138 Ordinary Shares Total Veraxa Biotech Ordinary Shares, including warrants, reported as beneficially owned

Ownership percentage 0.46% Percent of Veraxa Biotech Ordinary Shares class beneficially owned by AQR entities

Shared voting power 658,138 Shares over which AQR entities report shared power to vote or direct the vote

Shared dispositive power 658,138 Shares over which AQR entities report shared power to dispose or direct disposition

Par value CHF 100/11,325 per share Par value of Veraxa Biotech Ordinary Shares referenced in the ownership report

Key Terms

beneficially owned, shared voting power, shared dispositive power, warrants, +1 more

5 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 658,138"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"6 | Shared Voting Power 658,138.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"8 | Shared Dispositive Power 658,138.00"

warrants financial

"The reported amount includes warrants representing 658,138 Ordinary Shares"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

parent holding company financial

"If a parent holding company has filed this schedule, pursuant to (ii)(G)"

FAQ

What percentage of Veraxa Biotech (VRXA) shares does AQR report owning?

AQR and its affiliates report beneficial ownership of 0.46% of Veraxa Biotech Holding AG’s Ordinary Shares. This stake includes warrants representing 658,138 Ordinary Shares and is specifically identified as ownership of 5 percent or less of the class.

How many Veraxa Biotech (VRXA) shares are beneficially owned by AQR?

AQR and related entities report beneficial ownership of 658,138 Ordinary Shares of Veraxa Biotech Holding AG. The filing notes that this amount includes warrants representing 658,138 Ordinary Shares, all subject to shared voting and shared dispositive power.

Does AQR have sole or shared voting power over its Veraxa Biotech (VRXA) stake?

The AQR entities report 0 shares with sole voting power and 658,138 shares with shared voting power. They also report no sole dispositive power and shared dispositive power over the same 658,138 Veraxa Biotech Ordinary Shares.

Which AQR entities are reporting ownership in Veraxa Biotech (VRXA)?

The reporting persons are AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC is deemed controlled by AQR Capital Management, LLC.

What type of Veraxa Biotech (VRXA) securities are reported by AQR?

AQR reports holdings in Ordinary Shares of Veraxa Biotech Holding AG, with a par value of CHF 100/11,325 per share. The reported amount includes warrants representing 658,138 Ordinary Shares, all treated as part of the beneficially owned position.

Where are AQR’s principal offices related to its Veraxa Biotech (VRXA) holding?

The principal business office for the AQR reporting entities is listed as ONE GREENWICH PLAZA, SUITE 130, Greenwich, Connecticut 06830. All three entities report UNITED STATES as their citizenship or place of organization in connection with this Veraxa Biotech position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 12:12 PM Accepted by SEC EDGAR 08/13/2026 - 12:12 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Veraxa Biotech Holding AG f/k/a Voyager Acquisition Corp

(Name of Issuer)

Ordinary Shares, par value CHF 100/11,325 per share

(Title of Class of Securities)

H9130A103

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): H9130A103

1

Names of Reporting Persons

AQR Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 658,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 658,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

658,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.46 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): H9130A103

1

Names of Reporting Persons

AQR Capital Management Holdings, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 658,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 658,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

658,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.46 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): H9130A103

1

Names of Reporting Persons

AQR Arbitrage, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 658,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 658,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

658,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.46 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Veraxa Biotech Holding AG f/k/a Voyager Acquisition Corp
(b)	Address of issuer's principal executive offices: TALACKER 35, ZURICH, SWITZERLAND 8001
Item 2.
(a)	Name of person filing: AQR Capital Management, LLC AQR Capital Management Holdings, LLC AQR Arbitrage, LLC
(b)	Address or principal business office or, if none, residence: ONE GREENWICH PLAZA SUITE 130 Greenwich, Connecticut 06830
(c)	Citizenship: AQR Capital Management, LLC - UNITED STATES AQR Capital Management Holdings, LLC - UNITED STATES AQR Arbitrage, LLC - UNITED STATES
(d)	Title of class of securities: Ordinary Shares, par value CHF 100/11,325 per share
(e)	CUSIP No.: H9130A103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 658,138 The reported amount includes warrants representing 658,138 Ordinary Shares, par value CHF 100/11,325 per share
(b)	Percent of class: 0.46 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0 AQR Arbitrage, LLC - 0
	(ii) Shared power to vote or to direct the vote: AQR Capital Management, LLC - 658,138 AQR Capital Management Holdings, LLC - 658,138 AQR Arbitrage, LLC - 658,138
	(iii) Sole power to dispose or to direct the disposition of: AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0 AQR Arbitrage, LLC - 0
	(iv) Shared power to dispose or to direct the disposition of: AQR Capital Management, LLC - 658,138 AQR Capital Management Holdings, LLC - 658,138 AQR Arbitrage, LLC - 658,138
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Item 2(a) above.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AQR Capital Management, LLC

Signature:	Henry Parkin
Name/Title:	Authorized Signatory
Date:	08/13/2026

AQR Capital Management Holdings, LLC

Signature:	Henry Parkin
Name/Title:	Authorized Signatory
Date:	08/13/2026

AQR Arbitrage, LLC

Signature:	Henry Parkin
Name/Title:	Authorized Signatory
Date:	08/13/2026

Exhibit Information

AQR Capital Management Holdings, LLC, AQR Capital Management, LLC, and AQR Arbitrage, LLC hereby agree that this Schedule 13G is filed on behalf of each of the parties. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC. AQR Arbitrage, LLC is deemed to be controlled by AQR Capital Management, LLC.